Parameters | Clinical hyperthyroidism group (n = 39) | |
---|---|---|
Baseline | After treatment | |
Age, y | 40.31 ± 11.45 | 40.31 ± 11.45 |
Gender, M/F, n | 15/24 | 15/24 |
Weight (kg) | 54.60 ± 6.72 | 56.83 ± 6.38** |
BMI, kg/m2 | 20.67 ± 2.75 | 21.90 ± 2.54 |
SBP (mmHg) | 120 ± 9 | 118 ± 10 |
DBP (mmHg) | 76 ± 7 | 74 ± 7 |
TC (mM) | 3.63 ± 0.83 | 3.82 ± 0.76** |
TG (mM) | 1.10 ± 0.37 | 1.15 ± 0.34 |
LDLC (mM) | 1.51 ± 0.46 | 1.81 ± 0.51** |
HDLC (mM) | 1.48 ± 0.42 | 1.49 ± 0.35 |
ALT (IU/L) | 31 ± 21 | 32 ± 15 |
AST (IU/L) | 30 ± 11 | 31 ± 12 |
FT3 (pmol/L) | 14.68 ± 6.39 | 9.40 ± 4.59** |
FT4 (pmol/L)£ | 34.12 (27.61,48.93) | 25.69 (21.05,30.68)** |
TSH (pmol/L)£ | 0.006 (0.004,0.010) | 0.180 (0.094,0.400)** |
ZAG (mg/L) | 64.85 ± 12.84 | 55.72 ± 8.83** |